| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 01/14/2003 | US6506770 Antiviral compounds |
| 01/14/2003 | US6506767 8-chloro-6,11-dihydro-11-(4-piperidylidine)-5H-benzo[5,6]cyclohepta[1-2-b] pyridine |
| 01/14/2003 | US6506759 Retroviral protease inhibitors |
| 01/14/2003 | US6506758 Indole derivatives useful A.O. for the treatment of osteoporosis |
| 01/14/2003 | US6506756 Substituted imidazoles as dual histamine H1 and H3 agonists or antagonists |
| 01/14/2003 | US6506748 Aromatic heterocyclic compounds as antiinflammatory agents |
| 01/14/2003 | US6506747 Method of treating an inflammatory disease which comprises administering to a patient in need of such treatment-a N-(4-(5-Ethyl-3-pyridin-3-yl-pyrazol-1-yl)phenyl)pyridine-3-carboxamide; |
| 01/14/2003 | US6506743 2-nitromethylidene/2-cyanimino/2-nitro-imino-pyrrolidines and piperidines, intermediates, and their use as pesticides |
| 01/14/2003 | US6506572 Inhibitors of cellular niacinamide mononucleotide formation and their use in cancer therapy |
| 01/14/2003 | CA2252543C Benzene derivatives substituted by heterocycles and herbicides |
| 01/14/2003 | CA2217516C Triazole antifungal agent |
| 01/14/2003 | CA2217477C Tricyclic compounds useful for inhibition of farnesyl protein transferase |
| 01/13/2003 | WO2002006237A1 Medicine comprising dicyanopyridine derivative |
| 01/13/2003 | CA2415899A1 Medicine comprising dicyanopyridine derivative |
| 01/09/2003 | WO2003003008A1 Chemical libraries useful for drug discovery processes |
| 01/09/2003 | WO2003002974A2 Ecl labels having improved non-specific binding properties, methods of using and kits containing the same |
| 01/09/2003 | WO2003002561A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/09/2003 | WO2003002559A2 Piperidine compounds for use as orexin receptor antagonist |
| 01/09/2003 | WO2003002558A1 Remedial agent for viral infectious disease |
| 01/09/2003 | WO2003002556A1 Novel heteroaryl derivatives, their preparation and use |
| 01/09/2003 | WO2003002555A1 Methods of using soluble epoxide hydrolase inhibitors |
| 01/09/2003 | WO2003002554A1 Piperazine compounds |
| 01/09/2003 | WO2003002553A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2003002552A1 Novel indole derivatives |
| 01/09/2003 | WO2003002544A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/09/2003 | WO2003002542A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/09/2003 | WO2003002540A1 Cyclic diamine compound having five-membered cyclic group |
| 01/09/2003 | WO2003002538A1 Bis(2-aryl-5-pyridyl) derivative |
| 01/09/2003 | WO2003002537A1 Bis(5-aryl-2-pyridyl) derivative |
| 01/09/2003 | WO2003002534A1 Bis-piperidines |
| 01/09/2003 | WO2003002533A1 Triamide-substituted indoles, benzofuranes and benzothiophenes as inhibitors of microsomal triglyceride transfer protein (mtp) and/or apolipoprotein b (apo b) secretion |
| 01/09/2003 | WO2003002532A1 Cyclic diamine compounds having fused-ring groups |
| 01/09/2003 | WO2003002531A2 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2003002530A2 Pyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | WO2003002529A2 Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone |
| 01/09/2003 | WO2003002518A1 Novel 2,4-difluorobenzamide derivatives as antiviral agents |
| 01/09/2003 | WO2003002121A1 Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone |
| 01/09/2003 | WO2003002120A1 Polymorphic forms of 6-[4-(1-cyclohexyl-1h-tetrazol-5-yl)butoxy]-3, 4-dihydro-2(1h)-quinolinone |
| 01/09/2003 | WO2003002118A1 Substituted 8-arylquinoline pde4 inhibitors |
| 01/09/2003 | WO2003002109A2 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 01/09/2003 | WO2003002107A2 Use of tyrosine kinase inhibitors for treating multiple sclerosis (ms) |
| 01/09/2003 | WO2003002106A2 Use of tyrosine kinase inhibitions for treating allergic diseases |
| 01/09/2003 | WO2003002105A2 Use of tyrosine kinase inhibitors for treating bone loss |
| 01/09/2003 | WO2003002064A2 Fused pyrimidine dhfr inhibitors as antibacterials |
| 01/09/2003 | WO2003001887A2 Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors |
| 01/09/2003 | WO2002087587A3 4-aminosulfonylquinazolines and -quinolines as tyrosine kinase inhibitors |
| 01/09/2003 | WO2002059111A3 Pyrazole compounds useful as protein kinase inhibitors |
| 01/09/2003 | WO2002022579A3 Antipsychotic sulfonamide-heterocycles, and methods of use thereof |
| 01/09/2003 | WO2001098294A3 Vitronectin receptor antagonist pharmaceuticals for use in combination therapy |
| 01/09/2003 | WO2001072728B1 Novel piperazine derivatives |
| 01/09/2003 | US20030008915 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents |
| 01/09/2003 | US20030008909 For therapy of uterine myometrial fibroids, endometriosis, benign prostatic hypertrophy; carcinomas and adenocarcinomas of endometrium, ovary, breast, colon, prostate, pituitary, meningioma and other hormone-dependent tumors |
| 01/09/2003 | US20030008901 For therapy of arthritis, cancer, and other diseases characterized by matrix metalloproteinase or mammalian reprolysin activity |
| 01/09/2003 | US20030008899 For use as medicine for antagonising the effects of excitatory amino acids upon the NMDA receptor complex |
| 01/09/2003 | US20030008898 Indole derivatives and their use for the treatment of malignant and other diseases based on pathological proliferation |
| 01/09/2003 | US20030008896 Isoquinolinone derivatives |
| 01/09/2003 | US20030008894 Antimicrobial quinolones, their compositions and uses |
| 01/09/2003 | US20030008888 Novel cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 01/09/2003 | US20030008886 For therapy of pain |
| 01/09/2003 | US20030008883 4-Pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 01/09/2003 | US20030008881 Substituted phenylcyclohexanecarboxamides and their use |
| 01/09/2003 | US20030008879 For therapy of symptoms caused by withdrawal or partial withdrawal from the use of tobacco or of nicotine; for therapy of anxiety |
| 01/09/2003 | US20030008878 Administering benzimidazole compound for therapy of sexual dysfunction in a human |
| 01/09/2003 | US20030008877 CCR5 antagonists useful for treating AIDS |
| 01/09/2003 | US20030008874 1,3 disubstituted pyrrolidines as alpha -2- adrenoceptor antagonists |
| 01/09/2003 | US20030008868 Compounds useful as anti-inflammatory agents |
| 01/09/2003 | US20030008861 N-arylsulfonyl aza-bicyclic derivatives as potent cell adhesion inhibitors |
| 01/09/2003 | US20030008832 Method of inhibiting neoplastic cells with benzimidazole derivatives |
| 01/09/2003 | US20030007941 Method of treating hair loss using thyromimetic compounds |
| 01/09/2003 | US20030007927 Complexing drug to leukotrienes at infection, inflammation site |
| 01/09/2003 | CA2452390A1 Use of tyrosine kinase inhibitors for treating bone loss |
| 01/09/2003 | CA2452371A1 Use of tyrosine kinase inhibitors for treating allergic diseases |
| 01/09/2003 | CA2452361A1 Use of tyrosine kinase inhibitors for treating autoimmune diseases |
| 01/09/2003 | CA2452167A1 Use of tyrosine kinase inhibitors for treating multiple sclerosis (ms) |
| 01/09/2003 | CA2451840A1 Fused pyrimidine dhfr inhibitors as antibacterials |
| 01/09/2003 | CA2451800A1 Fused pyrimidines as d-alanyl-d-alanine ligase inhibitors |
| 01/09/2003 | CA2451464A1 N-aroyl cyclic amine derivatives as orexin receptor antagonists |
| 01/09/2003 | CA2451228A1 Novel heteroaryl derivatives, their preparation and use |
| 01/09/2003 | CA2451128A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/09/2003 | CA2451125A1 N-heterocyclic inhibitors of tnf-alpha expression |
| 01/09/2003 | CA2450722A1 Fluoropyrrolidines as dipeptidyl peptidase inhibitors |
| 01/09/2003 | CA2450686A1 Substituted 8-arylquinoline pde4 inhibitors |
| 01/09/2003 | CA2449486A1 Methods of using soluble epoxide hydrolase inhibitors |
| 01/08/2003 | EP1273582A1 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents |
| 01/08/2003 | EP1273581A1 New process for the preparation of the trihydrate of the magnesium salt of S-omeprazole |
| 01/08/2003 | EP1273580A1 Sulfonyl heteroaryl triazoles as anti-inflammatory and analgesic agents |
| 01/08/2003 | EP1273576A1 Sulfonyl aryl triazoles as anti-inflammatory/analgesic agents |
| 01/08/2003 | EP1273575A1 Diazepane derivatives or salts thereof |
| 01/08/2003 | EP1273572A1 Thiophene substituted piperazines useful in the treatment of benign prostatic hyperplasia |
| 01/08/2003 | EP1273571A1 Nitrogenous compounds and antiviral drugs containing the same |
| 01/08/2003 | EP1273298A2 Ritonavir in combination with an additional HIV protease inhibitor for treating aids |
| 01/08/2003 | EP1272484A2 Benzoamide piperidine compounds as substance p antagonists |
| 01/08/2003 | EP1272483A2 OXINDOLE INHIBITORS OF FACTOR Xa |
| 01/08/2003 | EP1272479A2 Novel compounds for enhancing chemotherapy |
| 01/08/2003 | EP1272478A1 Substituted phenyluracils |
| 01/08/2003 | EP1272477A1 Pyrimidine compounds |
| 01/08/2003 | EP1272474A1 Substituted 5-methyldihydropyridazinones and their use in the prophylaxis and/or treatment of anemias |
| 01/08/2003 | EP1272468A1 Indolin-2-one derivatives, preparation and their use as ocytocin receptor ligands |
| 01/08/2003 | EP1272193A2 Synergistic methods and compositions for treating cancer |
| 01/08/2003 | EP1272189A1 Inhibition of cyclooxygenase-2 activity |